These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 33166788)

  • 1. High circulating SDF-1and MCP-1 levels and genetic variations in CXCL12, CCL2 and CCR5: Prognostic signature of immune recovery status in treated HIV-positive patients.
    Yeregui E; Viladés C; Domingo P; Ceausu A; Pacheco YM; Veloso S; Inciarte A; Vidal-González J; Peraire M; Perpiñán C; Falcó V; Masip J; Alba V; Vargas M; Martí A; Reverté L; Mallolas J; Vidal F; Peraire J; Rull A
    EBioMedicine; 2020 Dec; 62():103077. PubMed ID: 33166788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of association of some chemokine system polymorphisms with the risks of death and hepatocellular carcinoma occurrence in patients with alcoholic cirrhosis: a prospective study.
    Nahon P; Sutton A; Rufat P; Faisant C; Simon C; Barget N; Trinchet JC; Beaugrand M; Gattegno L; Charnaux N
    Eur J Gastroenterol Hepatol; 2007 May; 19(5):425-31. PubMed ID: 17413295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Better CD4+ T cell recovery in Brazilian HIV-infected individuals under HAART due to cumulative carriage of SDF-1-3'A, CCR2-V64I, CCR5-D32 and CCR5-promoter 59029A/G polymorphisms.
    Rigato PO; Hong MA; Casseb J; Ueda M; de Castro I; Benard G; Duarte AJ
    Curr HIV Res; 2008 Sep; 6(5):466-73. PubMed ID: 18855658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of chemokine and chemokine receptor gene variants on the susceptibility and clinicopathological characteristics of bladder cancer.
    Kucukgergin C; Isman FK; Dasdemir S; Cakmakoglu B; Sanli O; Gokkusu C; Seckin S
    Gene; 2012 Dec; 511(1):7-11. PubMed ID: 22982413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCR5 genotype and pre-treatment CD4+ T-cell count influence immunological recovery of HIV-positive patients during antiretroviral therapy.
    Carvalho-Silva WHV; Andrade-Santos JL; Guedes MCDS; Crovella S; Guimarães RL
    Gene; 2020 May; 741():144568. PubMed ID: 32165289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic variation in CCR2 and CXCL12 genes impacts on CD4 restoration in patients initiating cART with advanced immunesupression.
    Restrepo C; Gutierrez-Rivas M; Pacheco YM; García M; Blanco J; Medrano LM; Navarrete-Muñoz MA; Gutiérrez F; Miralles P; Dalmau D; Gómez JL; Górgolas M; Cabello A; Resino S; Benito JM; Rallón N;
    PLoS One; 2019; 14(3):e0214421. PubMed ID: 30921390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic association of monocyte chemoattractant protein 1 (MCP-1)-2518 polymorphism in Mexican patients with transitional cell carcinoma of the bladder.
    Vázquez-Lavista LG; Lima G; Gabilondo F; Llorente L
    Urology; 2009 Aug; 74(2):414-8. PubMed ID: 19646633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of chemokine receptor gene polymorphisms on the response to potent antiretroviral therapy.
    O'Brien TR; McDermott DH; Ioannidis JP; Carrington M; Murphy PM; Havlir DV; Richman DD
    AIDS; 2000 May; 14(7):821-6. PubMed ID: 10839590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene polymorphisms in CCR5, CCR2, SDF1 and RANTES among Chinese Han population with HIV-1 infection.
    Li H; Liu TJ; Hong ZH
    Infect Genet Evol; 2014 Jun; 24():99-104. PubMed ID: 24650919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Association of chemokines and their receptors genes polymorphisms with risk of myocardial infarction].
    Xu X; Wang LH; Liu HB; Xu CF; Zhang P; Yong F; Shi YP
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2013 Oct; 30(5):601-7. PubMed ID: 24078580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution of four HIV type 1-resistance polymorphisms (CCR5-Delta32, CCR5-m303, CCR2-64I, and SDF1-3'A) in the Bahraini population.
    Salem AH; Farid E; Fadel R; Abu-Hijleh M; Almawi W; Han K; Batzer MA
    AIDS Res Hum Retroviruses; 2009 Oct; 25(10):973-7. PubMed ID: 19803715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemokine system polymorphisms, survival and hepatocellular carcinoma occurrence in patients with hepatitis C virus-related cirrhosis.
    Nahon P; Sutton A; Rufat P; Simon C; Trinchet JC; Gattegno L; Beaugrand M; Charnaux N
    World J Gastroenterol; 2008 Feb; 14(5):713-9. PubMed ID: 18205260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of CCR5-delta32, CCR2-64I and SDF-1-3'A polymorphic alleles on human immunodeficiency virus 1 (HIV-1) infection in the Polish population].
    Wasik TJ; Smoleń J; Kruszyński P; Bratosiewicz-Wasik J; Beniowski M
    Wiad Lek; 2005; 58(9-10):500-7. PubMed ID: 16529059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of CCR5, CCR2, CX3CR1, and SDF1 polymorphisms in HIV-positive treated patients: impact on response to HAART and on peripheral T lymphocyte counts.
    Puissant B; Roubinet F; Massip P; Sandres-Saune K; Apoil PA; Abbal M; Pasquier C; Izopet J; Blancher A
    AIDS Res Hum Retroviruses; 2006 Feb; 22(2):153-62. PubMed ID: 16478397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of highly active antiretroviral therapy failure with chemokine receptor 5 wild type.
    Bogner JR; Lutz B; Klein HG; Pollerer C; Troendle U; Goebel FD
    HIV Med; 2004 Jul; 5(4):264-72. PubMed ID: 15236615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CCR2, CCR5, and CXCL12 variation and HIV/AIDS in Papua New Guinea.
    Mehlotra RK; Hall NB; Bruse SE; John B; Zikursh MJB; Stein CM; Siba PM; Zimmerman PA
    Infect Genet Evol; 2015 Dec; 36():165-173. PubMed ID: 26397046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of HIV-1 resistance-conferring polymorphic alleles SDF-1-3'A, CCR2-64I and CCR5-Delta32 in diverse populations of Andhra Pradesh, South India.
    Ramana GV; Vasanthi A; Khaja M; Su B; Govindaiah V; Jin L; Singh L; Chakraborty R
    J Genet; 2001 Dec; 80(3):137-40. PubMed ID: 11988632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of polymorphisms in the chemokine system in the susceptibility for coronary artery disease (CAD). Coincidence of elevated Lp(a) and MCP-1 -2518 G/G genotype in CAD patients.
    Szalai C; Duba J; Prohászka Z; Kalina A ; Szabó T; Nagy B; Horváth L; Császár A
    Atherosclerosis; 2001 Sep; 158(1):233-9. PubMed ID: 11500196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Causal pathways of the effects of age and the CCR5-Delta32, CCR2-64I, and SDF-1 3'A alleles on AIDS development.
    Geskus RB; Meyer L; Hubert JB; Schuitemaker H; Berkhout B; Rouzioux C; Theodorou ID; Delfraissy JF; Prins M; Coutinho RA
    J Acquir Immune Defic Syndr; 2005 Jul; 39(3):321-6. PubMed ID: 15980693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution of CCR-5Δ32, CCR2-64I, and SDF-1-3'A alleles among Jordanians.
    Khabour OF; Abu-Haweleh LJ; Alzoubi KH
    AIDS Res Hum Retroviruses; 2013 Jan; 29(1):151-5. PubMed ID: 22770415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.